LA JOLLA, CA, April 30, 2024 – Enlaza Therapeutics, the first covalent biologic platform company, today announced a $100 million Series A financing. The financing will be used to further...
Art Pappas will speak on "Later Stage Venture Funding" at the University of North Carolina at Chapel Hill's Technology Commercialization Workshop in Chapel Hill.
News | 10. 21. 2010
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.